Literature DB >> 8327079

Facial myokymia and spastic paretic facial contracture as the result of anaplastic pontocerebellar glioma.

J K Krauss1, A K Wakhloo, R Scheremet, W Seeger.   

Abstract

The case of a 36-year-old man who sought treatment of right facial myokymia and spastic paretic facial contracture is reported. Computed tomography and magnetic resonance imaging revealed a tumor located in the right cerebellar peduncle and the right dorsal pons bulging into the fourth ventricle. After microsurgical partial resection of the mass, which was verified histologically as an anaplastic glioma, facial myokymia initially ceased. The vermicular rippling movements were less intense upon recurrence and could be controlled by low-dose dexamethasone in the further course, when magnetic resonance imaging showed an interstitial pontine edema after percutaneous radiation therapy. It is assumed that facial myokymia and spastic paretic facial contracture were generated by ectopic activity due to alterations in the microenvironment at the intrapontine portion of the axons of the seventh nerve caused by the compressive effect of the tumor and later by edema.

Entities:  

Mesh:

Year:  1993        PMID: 8327079     DOI: 10.1227/00006123-199306000-00027

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

1.  Hemifacial spasm caused by pontine glioma: case report and review of the literature.

Authors:  Essam A Elgamal; Hugh B Coakham
Journal:  Neurosurg Rev       Date:  2005-07-07       Impact factor: 3.042

Review 2.  Facial spasms, but not hemifacial spasm: a case report and review of literature.

Authors:  Michael M McDowell; Xiao Zhu; Marion A Hughes; Raymond F Sekula
Journal:  Childs Nerv Syst       Date:  2016-03-16       Impact factor: 1.475

Review 3.  Immediate disappearance of hemifacial spasm after partial removal of ponto-medullary junction anaplastic astrocytoma: case report.

Authors:  Melina Castiglione; Morgan Broggi; Roberto Cordella; Francesco Acerbi; Paolo Ferroli
Journal:  Neurosurg Rev       Date:  2014-11-11       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.